Dr Reddy#39;s gets EIR from USFDA for 2 units at Medak

Dr Reddy#39;s gets EIR from USFDA for 2 units at Medak In an earlier filing to the bourses on March 9, the drug firm had said it had received five observations from the US Food and Drug Administration (USFDA) for its API Hyderabad plant 3 at Medak district.

No comments:

Post a Comment